key: cord-1050606-994insf6
authors: Banihani, Saleem Ali
title: Human semen quality as affected by SARS‐CoV‐2 infection: An up‐to‐date review
date: 2021-10-30
journal: Andrologia
DOI: 10.1111/and.14295
sha: b5140c3cc7df18d20c2ba4bfcc12990376d2d752
doc_id: 1050606
cord_uid: 994insf6

Revealing the effect of SARS‐CoV‐2 infection on semen quality is a dynamic priority for many healthcare providers in the field as well as subfertile patients. Therefore, the collective summary in this research approach is still highly needed, especially with the continuous increase in original publications. Here, we provide an up‐to‐date review and discussion to collectively reveal the effect of SARS‐CoV‐2 infection on human semen quality. To do this, we reviewed all articles and abstracts published in Scopus and PubMed using the keywords ‘SARS‐CoV‐2’ and ‘COVID’ versus ‘sperm’ and ‘semen’. In summary, it can be revealed that, at both symptomatic and recovery stages of infection, no investigational evidence of SARS‐CoV‐2 shedding in human semen. Also, the mainstream of the up‐to‐date published work reveals a negative impact of SARS‐CoV‐2 infection on semen quality parameters, particularly sperm count and motility. However, long‐term post‐recovery comparative studies seem very important in this particular setting.

The 2020 coronavirus outbreak, which is caused by SARS-CoV-2 (a virus belonging to the family Coronaviridae and cause , is an unexpected global situation. It has become an extraordinary challenge for health systems in various countries, since, in one important lateral, various health policies as well as medical protocols and procedures had to mandatory be reviewed and renovated to flatten the mounting curve of infected people. This renovation or makeover includes the main protocols and procedures in andrology laboratories to avoid any possible negative effects on, for instance, assisted reproductive technologies outcomes. For example, various andrology laboratories in the assisted reproductive technologies units have requested negative coronavirus tests for males undergoing in vitro fertilization. Therefore, revealing the effect of SARS-CoV-2 infection on semen quality and sperm parameters, which mimicked principally in sperm quality and quantity (Banihani, 2017) , is of great importance at this time, particularly for healthcare providers (e.g. andrologists, urologists and embryologists), researchers in the field and patients with COVID-19. Accordingly, this work discusses and summarizes such effect considering, mainly, all original studies published in this research approach as per Scopus and PubMed databases.

To date, there are more than 50 published articles in Scopus and PubMed databases that are linking between SARS-CoV-2 infection and semen quality. To extract, review and collectively summarize these studies, we have searched these databases using the keywords 'SARS- relevant articles to support the discussion, and hence to frame the up-to-date summary in this context of research, were considered and cited.

Angiotensin-converting enzyme 2 (ACE-2) has been recognized to be the cell entry receptor for SARS-CoV-2 (Doyle et al., 2021; Hoffmann et al., 2020; . This receptor was not only found to be localized in the lungs, but also in the testes (Barker & Parkkila, 2020; Fu et al., 2020; Wang & Xu, 2020) . Accordingly, it was hypothesized that the testes, and hence the semen, are targets for SARS-CoV-2 (Cardona Maya et al., 2020) . Consequently, in effect, it is suggested that the presence of SARS-CoV-2 in semen may negatively affect sperm parameters and hence male fertility. In addition, this may have implications for sexual spread and consequently, for example, congenital disease, embryonic infection and miscarriage (Rodriguez Bustos et al., 2021) . Such rationale explains the designation of several research studies to probe the presence of SARS-CoV-2 in human semen.

Research studies conducted to test the presence of SARS-CoV-2 in human semen and the effects SARS-CoV-2 on sperm parameters (Pazir et al., 2021) vitro fertilization and intracytoplasmic sperm injection) and sexual contact.

As presented in Table 1 Further, as indicated in Table 1 , six of the studies conducted on the effect of SARS-CoV-2 infection on sperm parameters have revealed negative effects on sperm parameters. Accordingly, to date, it can be concluded that the mainstream of research appears to reveal an effect of the SARS-CoV-2 infection on sperm parameters, peculiarly sperm count. However, in fact, further research studies are still highly acknowledged in this specific gap of information to provide a more robust and a collective conclusion, especially, given that SARS-CoV-2 was not detected in semen as discussed above.

In human males, spermatogenesis is under control by gonadal hormones, mainly luteinizing hormone, follicle-stimulating hormone and testosterone (Achard et al., 2009; Banihani, 2018; Bremner et al., 1981; Sharpe et al., 1992) . Specifically, it was found that the number of Leydig cells in the testes is controlled by luteinizing hormone and follicle-stimulating hormone (Duckett et al., 1997; Teerds et al., 1989; Verhagen et al., 2014) . These hormones promote the synthesis of testosterone in the testes (Baburski et al., 2019; Banihani, 2019a; Ewing et al., 1983) . Testosterone is synthesized primarily in Leydig cells, and the amount of testosterone formed was found to be under control by luteinizing hormone via controlling expression of 17β-hydroxysteroid dehydrogenase (Banihani, 2019b; Zhou et al., 2014) . It has been shown that patients with COVID-19 had lower levels of luteinizing hormone and testosterone compared with healthy individuals (Salonia et al., 2021) . In addition, COVID-19 patients were found to have higher level of luteinizing and prolactin and lower level of total testosterone compared with control . Also, serious COVID-19 cases were found to induce further reduction in total testosterone level . In fact, clinically, increased serum levels of luteinizing hormone and decreased testosterone:luteinizing hormone ratio reveal testicular dysfunction, which consequently may impact spermatogenesis (Holm et al., 2003) . Accordingly, the observed negative effect of SARS-CoV-2 infection on sperm parameters may be because, albeit partially, of reduced production of testosterone. However, further confirmatory studies in this research setting seem to be very imperative.

Mechanistically, it has been shown that the entry of SARS-CoV-2 into the cell depends on ACE-2 and transmembrane serine protease 2 (Hoffmann et al., 2020; Liu et al., 2020; Sakamoto et al., 2021) .

However, it has been shown that transmembrane serine protease 2 is expressed only in a subpopulation of germ cells during development, while ACE-2 is mostly transcribed in Sertoli cells (Wang et al., 2018) . Also, it was suggested that ACE-2 and transmembrane serine protease 2 do not overlap and have a limited expression in testicular tissue (Anifandis et al., 2021; Pan et al., 2020) . Accordingly, such evidence, however indirectly, supports the concept that the entrance of virus into testis tissue is unlikely to occur. Indeed, however this is a partial support, as collectively concluded from this review, SARS-CoV-2 was not detected in seminal fluid.

In general, fever of more than or equal to 39°C for more than or equal to three days can lead to severe impairment to semen quality and, in the worst-case scenario, to azoospermia (Jung et al., 2001) .

It has been recognized that a fever at even limited duration of time may significantly reduce sperm parameters (e.g. count, motility and/ or vitality) and alter integrity of sperm DNA (Bendayan & Boitrelle, 2021; Durairajanayagam et al., 2015; Sergerie et al., 2007) . As a consequence, it is worth mentioning that the arrival to the basal level of the altered sperm parameters may relatively take long time (at least 3 months) (Bendayan & Boitrelle, 2021; Lazarus & Zorgniotti, 1975) .

Therefore, given that fever is a symptom that can be seen in more than 80% of infected people with COVID-19, then fever-induced COVID-19, even in the absence of immune response and the virus in the semen, can alter semen quality and reduce sperm parameters.

Such negative effect on semen quality could have more impact on subfertile men.

Even though, in general, the testes are most of time unaffected by host response to antigens compared with other bodily organs (Zhao et al., 2014) , it is found that several expressed proteins were downregulated in testicular tissues from autopsy samples of COVID-19 patients (Nie et al., 2021) , which suggests unusual physiological processes in the testis during the COVID-19 for those patients.

For example, insulin-like factor-3, which is the most expressed protein in testicular tissue, particularly in Leydig cells (Uhlen et al., 2015) , was found to be markedly reduced in testicular tissue of COVID-19 (Nie et al., 2021) . This reduction was suggested to impair the function and/or the population of Leydig cells (Nie et al., 2021) .

Moreover, the E3 ubiquitin-protein ligase, which is a crucial enzyme for spermatogenesis (Melnick et al., 2019; Richburg et al., 2014) , and the dynein regulatory complex subunit-7, which is an essential factor for motility of spermatozoa (Morohoshi et al., 2020; Wirschell et al., 2013) , were found to be reduced in COVID-19 patients, indicating an impairment in spermatogenesis and sperm function as a result of SARS-CoV-2 infection (Nie et al., 2021) .

In addition, autopsied testicular samples of COVID-19 were found to have several histological/physiological disorders such as erythrocytes exudation in the epididymides and the testes and thinning in seminiferous tubules . Further, in COVID-19, seminiferous tubules had higher number of apoptotic cells compared with control . Furthermore, testes from patients with COVID-19 were found to have reduced Leydig cells and injured seminiferous tubules . Furthermore, a study con- with mild-to-moderate cases . Surprisingly, even though all diagnosed patients were asymptomatic regarding scrotal complaints, approximately 42% of men were found to have epididymitis, 54.5% with enlarged epididymal head, and 19.2% with bilateralism. In effect, this deleterious effect on the testes was suggested to be indirect and mediated by cytokines as theorized by

Hallak and his coworkers .

It has been shown that immunohistochemistry of autopsied samples showed presence of IgG, which is the main antibody in the extracellular fluid of the body, within seminiferous tubules and increased concentrations of CD68+ (macrophages) and CD3+ (T lymphocytes)

in interstitial cells of testicular tissue . In addition, it showed higher seminal concentrations of immune factors such as tumour necrosis factorα, interleukin-6 and monocyte chemoattractant protein-1 .

In November (2020) broad complex-tramtrack-bric a brac and Cap'n'collar homology 2 (Bach2)/Batf pathway, and, consequently, the disturbed interleukin-4 reduces ACE-2 level with the inflammation, which further has a negative impact on male fertility in patients with COVID-19 (Renu et al., 2020) , though, such mechanistic hypothesis requires approval by experimental work.

Furthermore, the multi-organ and tissue injury that can be seen in COVID-19, particularly in severe cases, may be attributable to several immunological mechanisms. One remarkable contributable mechanism is the cytokine storm (Tisoncik et al., 2012) , also called cytokine-release syndrome (CRS), which is an enhanced inflammatory cytokine (e.g. IL-1, IL-6 and IL-10 (Qin et al., 2020)) release results from excessive proliferation of immune cells .

Other recognized mechanisms in COVID-19 that seem to contribute to tissue damage and multi-organ dysfunction are the haemophagocytic lympho-histiocytosis (HLH), also called haemophagocytic syndrome, which is a substantial systemic inflammatory syndrome, and

the T-cell dysregulation . Such immunologically induced multi-organ damage also includes testicular damage, which may negatively impact spermatogenesis, and hence the quality of semen produced.

In conclusion, to date, at this stage of research, it can be revealed that no investigational evidence of SARS-CoV-2 shedding in human semen at both symptomatic and recovery stages of infection.

However, further confirmatory studies, particularly the ones that include larger study population, are still desired.

On the other hand, however it is inconsistent, the mainstream of the up-to-date research revealed adverse effects of SARS-CoV-2 infection on sperm parameters, peculiarly on sperm concentration.

But, at this phase of investigation, especially with the absence of SARS-CoV-2 in semen, further studies are still of great importance to release confident evidence towards this effect in this specific gap of knowledge. In addition, longer-term studies as well as comparative observational analytic studies (i.e. studies that investigate sperm parameters before and after the infection) seem to have impact in this particular setting to ensure the reversibility of sperm parameters in the infected patients.

Mechanistically, SARS-CoV-2 infection, initially and regardless of irreversibility, was found to induce testicular injury and reduce testicular function; in particular, this may be occurred, at least in part, by an alteration in gonadal hormones or as a consequence of immunological and inflammatory responses.

The authors declare no conflict of interest.

Data sharing is not applicable to this article as no data sets were generated during the current study.

Saleem Ali Banihani https://orcid.org/0000-0002-6830-6247

Normal spermatogenesis in a man with mutant luteinizing hormone

COVID-19 and human reproduction: A pandemic that packs a serious punch

Luteinizing hormone signaling is involved in synchronization of Leydig cell's clock and is crucial for rhythm robustness of testosterone productiondagger

Semen quality as affected by olive oil

Ginger and testosterone

Mechanisms of honey on testosterone levels

Testosterone in males as enhanced by onion (Allium cepa L.)

Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2

COVID-19: semen impairment may not be related to the virus

Evaluation of SARS-CoV-2 in human semen and effect on total sperm number: a prospective observational study

Follicle-stimulating hormone and human spermatogenesis

A cohort study of men infected with COVID-19 for presence of SARS-CoV-2 virus in their semen

SARS-CoV-2 and the testis: similarity with other viruses and routes of infection

Radiological patterns of incidental epididymitis in mild-to-moderate COVID-19 patients revealed by colour Doppler ultrasound

Human type II taste cells express angiotensin-converting enzyme 2 and are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Testicular pathology in fatal COVID-19: A descriptive autopsy study. Andrology

The effects of gonadotropin-releasing hormone immunization and recombinant follicle-stimulating hormone on the Leydig cell and macrophage populations of the adult rat testis

Causes, effects and molecular mechanisms of testicular heat stress

Short-term effects of COVID-19 on semen parameters: a multicenter study of 69 cases

Effect of luteinizing hormone on Leydig cell structure and testosterone secretion

Expressions and significances of the angiotensinconverting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19

Absence of SARS-CoV-2 in semen of a COVID-19 patient cohort

SARS-CoV-2 and its relationship with the genitourinary tract: Implications for male reproductive health

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio

Risks associated with cryopreserved semen in a human sperm bank during and after the COVID-19 pandemic

Fever as etiology of temporary infertility in the man

SARS-CoV-2 pneumonia affects male reproductive hormone levels: A prospective, Cohort Study

Thermoregulation of the human testis

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2

RNF216 is essential for spermatogenesis and male fertility dagger

Nexin-Dynein regulatory complex component DRC7 but not FBXL13 is required for sperm flagellum formation and male fertility in mice

Multi-organ proteomic landscape of COVID-19 autopsies

No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019

Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab

Impaired semen parameters in patients with confirmed SARS-CoV-2 infection: a prospective cohort study

The role of Interleukin-4 in COVID-19 associated male infertility -A hypothesis

The role of E3 ligases in the ubiquitin-dependent regulation of spermatogenesis

Effects of COVID-19 on male sex function and its potential sexual transmission

No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: a perspective and urogenital evaluation

ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart

Severely low testosterone in males with COVID-19: A case-control study

High risk of temporary alteration of semen parameters after recent acute febrile illness

Testosterone and spermatogenesis. Identification of stage-specific, androgen-regulated proteins secreted by adult rat seminiferous tubules

Effects of pure FSH and LH preparations on the number and function of Leydig cells in immature hypophysectomized rats

SARS-CoV-2 and Multi-Organ damage -What men's health specialists should know about the COVID-19 pathophysiology

Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: a cross-sectional, pilot study

Into the eye of the cytokine storm

Proteomics. Tissue-based map of the human proteome. Science

Time course and role of luteinizing hormone and follicle-stimulating hormone in the expansion of the Leydig cell population at the time of puberty in the rhesus monkey (Macaca mulatta)

Single-cell RNA sequencing analysis reveals sequential cell fate transition during human spermatogenesis

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

scRNA-seq profiling of human testes reveals the presence of the ACE2 Receptor, a target for SARS-CoV-2 infection in spermatogonia, leydig and sertoli cells

The nexin-dynein regulatory complex subunit DRC1 is essential for motile cilia function in algae and humans

Pathological findings in the testes of COVID-19 patients: clinical implications

Testicular defense systems: immune privilege and innate immunity

11beta-hydroxysteroid dehydrogenase types 1 and 2 in postnatal development of rat testis: gene expression, localization and regulation by luteinizing hormone and androgens

Human semen quality as affected by SARS-CoV-2 infection: An up-to-date review